List view / Grid view
A new report has predicted that, even though the healthcare sector has been slow on the uptake, blockchain will play a pivotal role, creating new ways for pharmaceutical stakeholders to exchange information.
Researchers have discovered that pharma companies see the most need to invest in data protection and cybersecurity over other technologies.
According to a new report, blockchain technology in the healthcare market size is set to increase exponentially.
A multi-company system to improve traceability of pharmaceutical products is newly supported by the FDA.
Walmart has joined a consortium that’s attempting to build a blockchain for tracking pharmaceutical supply chains.
Blockchain technologies have the potential to improve transparency, efficiency and reliability of transactions in a heavily regulated pharmaceutical industry. However, there are challenges and limitations. Nikki Withers speaks to Bob Celeste, founder of the Centre for Supply Chain Studies, who has been exploring the potential use of blockchain technology to…
US researchers have created a proof-of-concept method for ensuring the integrity of clinical trials data using blockchain...
In this issue we look at the challenges of shipping temperature-controlled products, the potential use of blockchain for pharma, and using MALDI-TOF for identification of peptides in suspected illegal medicinal products. The edition also includes articles on aseptic containment, legal advice on licensing negotiations and an In-Depth Focus article from…
Corporate codes of ethics can have reverse effects and mask anomalies or social evils in operations outsourced to low-wage countries...
Just under a quarter (22%) of life science companies already using or experimenting with blockchain, but industry collaboration over security and storage standards is needed…
